Cite

HARVARD Citation

    Lee, Y. et al. (n.d.). No Benefit of Hypomethylating Agents Compared to Supportive Care for Higher Risk Myelodysplastic Syndrome by IPSS-R. Leukemia research. pp. S65-. [Online]. 
  
Back to record